Mersana Therapeutics Stock (NASDAQ: MRSN) stock price, news, charts, stock research, profile.
Open | $2.18 |
Close | $2.16 |
Volume / Avg. | 1.34M / 1.27M |
Day Range | $2.13 - $2.22 |
52 Wk Range | 1.07 - 6.28 |
Market Cap | $265.92M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 11.02% |
Days to Cover | 10.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mersana Therapeutics (NASDAQ:MRSN) through any online brokerage.
Other companies in Mersana Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), PepGen (NASDAQ:PEPG), Adaptimmune Therapeutics (NASDAQ:ADAP) and Kyverna Therapeutics (NASDAQ:KYTX).
Mersana Therapeutics has a consensus price target of $6.38.
The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $2.1677 last updated September 20, 2024 at 8:00 AM EDT.
There are no upcoming dividends for Mersana Therapeutics.
Mersana Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Mersana Therapeutics.
Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.